GLP 1
Amycretin Complete Guide: Novo’s Oral Dual-Agonist Explained
Introduction Amycretin is one of the most closely watched obesity drugs in development, and the reason is simple: it is a single molecule that…
Alcohol Moderation Strategies That Stick Post-GLP-1
Introduction The strange truth about alcohol and GLP-1 medications is that many patients moderate effortlessly during treatment and then struggle after, because the medication…
Air Fryer High-Protein Recipes: Quick GLP-1 Dinners
An air fryer is a strong fit for GLP-1 dinners because it cooks protein quickly with minimal oil and almost no cleanup.
ACA Marketplace Plans and GLP-1: 2027 Open Enrollment Guide
Introduction ACA marketplace plans cover GLP-1 drugs inconsistently, so the 2027 open enrollment is your chance to compare formularies and pick a plan that…
A1C 5.7 to 6.4: Your GLP-1 Decision Framework
An A1C between 5.7% and 6.4% puts you in prediabetes, and the right move depends on where in that band you sit plus your other risk factors.
The 6-Month Maintenance Checkpoint: Audit Your Systems
Six months after reaching your goal weight is exactly when you should sit down and audit every system that got you there.
The 5-Year View: Long-Term GLP-1 Users Tell the Truth
Five years into GLP-1 treatment, the people doing well share one belief: this is chronic disease management, not a diet with an end date.
GLP-1 Medications and Eating Disorders in Recovery: What Providers Recommend
People in eating disorder recovery who also have obesity face a clinical challenge that most GLP-1 prescribing guidance was not designed to address. Standard…
GLP-1 Medications for Caregivers: How to Fit Treatment Into a Demanding Life
There is a particular kind of exhaustion that comes from caring for someone else full-time. The schedule is not yours, the meals often are…